WOOF Petco Health & Wellness Company, Inc.
Retail-Retail Stores, NEC · Nasdaq · SEC CIK 1826470 · Fiscal year ends 01/30
Financial factors as of 2026-08-01 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY-1.3%
TTM net income YoY207.3%
TTM EPS YoY200.0%
Revenue 3-yr CAGR-1.1%
Net income 3-yr CAGR-5.8%
Margins
Gross margin38.8%
Operating margin2.2%
Net margin0.5%
FCF margin4.0%
EBITDA margin5.5%
Returns
ROE2.6%
ROA0.6%
ROIC (approx.)6.6%
Asset turnover1.16x
Leverage & solvency
Liabilities / assets76.6%
Debt / equity0.50x
Current ratio0.90x
Interest coverage1.03x
Cash quality & payout
Operating cash flow / net income12.36x
Accruals ratio-6.7%
Payout ratio—
Capex / revenue2.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252026-01-31 | FY20242025-02-01 | FY20232024-02-03 | FY20222023-01-28 | FY20212022-01-29 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $5.96B | $6.12B | $6.26B | $6.04B | $5.81B |
| Cost of revenue | $3.66B | $3.79B | $3.90B | $3.61B | $3.38B |
| Gross profit | $2.31B | $2.32B | $2.35B | $2.43B | $2.43B |
| SG&A expense | $2.18B | $2.32B | $2.31B | $2.20B | $2.16B |
| Operating income | $120.43M | $7.05M | -$1.18B | $225.56M | $266.07M |
| Interest expense | $131.20M | $143.53M | $150.91M | $101.64M | $77.40M |
| Pretax income | $15.33M | -$109.30M | -$1.31B | $112.28M | $202.40M |
| Income tax | $6.27M | -$7.48M | -$27.61M | $35.35M | $53.47M |
| Net income | $9.07M | -$101.82M | -$1.28B | $90.80M | $164.42M |
| EBITDA | $317.14M | $215.57M | -$976.70M | $419.39M | $438.50M |
| EPS (basic) | 0.03 | -0.37 | -4.78 | 0.34 | 0.62 |
| EPS (diluted) | 0.03 | -0.37 | -4.78 | 0.34 | 0.62 |
| Weighted avg. shares (diluted) | 286.15M | 273.41M | 267.55M | 265.95M | 265,338 |
| Balance sheet | |||||
| Cash & equivalents | $256.74M | $181.66M | $136.65M | $213.73M | $221.89M |
| Receivables | $45.81M | $40.42M | $44.37M | $49.58M | $55.62M |
| Inventory | $590.21M | $653.33M | $684.50M | $652.43M | $675.11M |
| Current assets | $1.02B | $973.62M | $951.74M | $1.02B | $1.07B |
| PP&E, net | $656.15M | $725.44M | $816.37M | $803.33M | $726.92M |
| Goodwill | $980.06M | $980.06M | $980.30M | $2.19B | $2.18B |
| Total assets | $5.17B | $5.19B | $5.36B | $6.61B | $6.50B |
| Current liabilities | $1.13B | $1.14B | $1.11B | $1.02B | $1.05B |
| Short-term debt | $4.61M | $5.35M | $15.96M | $22.79M | $21.76M |
| Long-term debt | $0 | $1.58B | $1.58B | $1.63B | $1.64B |
| Total debt | $4.61M | $1.58B | $1.59B | $1.65B | $1.66B |
| Total liabilities | $4.01B | $4.08B | $4.18B | $4.23B | $4.24B |
| Shareholders' equity | $1.16B | $1.11B | $1.18B | $2.38B | $2.27B |
| Net debt | -$252.13M | $1.40B | $1.46B | $1.44B | $1.44B |
| Cash flow statement | |||||
| Operating cash flow | $314.05M | $177.67M | $215.72M | $346.00M | $358.21M |
| Capital expenditure | $127.10M | $127.99M | $225.60M | $278.02M | $239.11M |
| Free cash flow | $186.95M | $49.68M | -$9.88M | $67.98M | $119.11M |
| Investing cash flow | -$124.56M | -$123.90M | -$207.44M | -$320.32M | -$237.08M |
| Financing cash flow | -$101.75M | -$8.75M | -$85.35M | -$33.84M | -$18.78M |
| Depreciation & amortization | $196.71M | $208.52M | $203.62M | $193.83M | $172.43M |
| Stock-based compensation | $32.65M | $50.21M | $81.86M | $60.78M | $49.27M |
Free plan shows the latest 5 periods; Pro shows all 7 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.